Unknown

Dataset Information

0

Application of 4D-QSAR studies to a series of raloxifene analogs and design of potential selective estrogen receptor modulators.


ABSTRACT: Four-dimensional quantitative structure-activity relationship (4D-QSAR) analysis was applied on a series of 54 2-arylbenzothiophene derivatives, synthesized by Grese and coworkers, based on raloxifene (an estrogen receptor-alpha antagonist), and evaluated as ERa ligands and as inhibitors of estrogen-stimulated proliferation of MCF-7 breast cancer cells. The conformations of each analogue, sampled from a molecular dynamics simulation, were placed in a grid cell lattice according to three trial alignments, considering two grid cell sizes (1.0 and 2.0 Å). The QSAR equations, generated by a combined scheme of genetic algorithms (GA) and partial least squares (PLS) regression, were evaluated by "leave-one-out" cross-validation, using a training set of 41 compounds. External validation was performed using a test set of 13 compounds. The obtained 4D-QSAR models are in agreement with the proposed mechanism of action for raloxifene. This study allowed a quantitative prediction of compounds' potency and supported the design of new raloxifene analogs.

SUBMITTER: Sodero AC 

PROVIDER: S-EPMC6268799 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Application of 4D-QSAR studies to a series of raloxifene analogs and design of potential selective estrogen receptor modulators.

Sodero Ana Carolina Rennó AC   Romeiro Nelilma Correia NC   da Cunha Elaine Fontes Ferreira EF   de Oliveira Magalhaães Uiaran U   de Alencastro Ricardo Bicca RB   Rodrigues Carlos Rangel CR   Cabral Lúcio Mendes LM   Castro Helena Carla HC   Albuquerque Magaly Girão MG  

Molecules (Basel, Switzerland) 20120615 6


Four-dimensional quantitative structure-activity relationship (4D-QSAR) analysis was applied on a series of 54 2-arylbenzothiophene derivatives, synthesized by Grese and coworkers, based on raloxifene (an estrogen receptor-alpha antagonist), and evaluated as ERa ligands and as inhibitors of estrogen-stimulated proliferation of MCF-7 breast cancer cells. The conformations of each analogue, sampled from a molecular dynamics simulation, were placed in a grid cell lattice according to three trial al  ...[more]

Similar Datasets

| S-EPMC6263259 | biostudies-literature
| S-EPMC6399299 | biostudies-literature
| S-EPMC2952686 | biostudies-literature
| S-EPMC5523444 | biostudies-other
| S-EPMC3955358 | biostudies-literature
| S-EPMC4285377 | biostudies-literature
| S-EPMC8381776 | biostudies-literature
| S-EPMC2802893 | biostudies-literature
| S-EPMC5259750 | biostudies-literature
| S-EPMC3488830 | biostudies-literature